[Federal Register Volume 77, Number 58 (Monday, March 26, 2012)]
[Notices]
[Pages 17529-17530]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-7184]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Notice of Charter Renewal: Advisory Committee on the Medical Uses
of Isotopes
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: This notice is to announce the renewal of the Advisory
Committee on the Medical Uses of Isotopes (ACMUI) for a period of two
years.
-----------------------------------------------------------------------
SUPPLEMENTARY INFORMATION: The U.S. Nuclear Regulatory Commission (NRC)
has determined that the renewal of the Charter for the Advisory
Committee on the Medical Uses of Isotopes for the two year period
commencing on March 14, 2012 is in the public interest, in connection
with duties imposed on the Commission by law. This action is being
taken in accordance with the Federal Advisory Committee Act, after
consultation with the Committee Management Secretariat, General
Services Administration.
The purpose of the ACMUI is to provide advice to NRC on policy and
technical issues that arise in regulating the medical use of byproduct
material for diagnosis and therapy. Responsibilities include providing
guidance and comments on current and proposed NRC regulations and
regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use;
[[Page 17530]]
and evaluating training and experience of proposed authorized users.
The members are involved in preliminary discussions of major issues in
determining the need for changes in NRC policy and regulation to ensure
the continued safe use of byproduct material. Each member provides
technical assistance in his/her specific area(s) of expertise,
particularly with respect to emerging technologies. Members also
provide guidance as to NRC's role in relation to the responsibilities
of other Federal agencies as well as of various professional
organizations and boards.
Members of this Committee have demonstrated professional
qualifications and expertise in both scientific and non-scientific
disciplines including nuclear medicine; nuclear cardiology; radiation
therapy; medical physics; nuclear pharmacy; State medical regulation;
patient's rights and care; health care administration; and Food and
Drug Administration regulation.
FOR FURTHER INFORMATION CONTACT: Ashley Cockerham, Office of Federal
and State Materials and Environmental Management Programs, U.S. Nuclear
Regulatory Commission, Washington, DC 20555; Telephone (240) 888-7129;
email [email protected].
Dated: March 19, 2012.
Andrew L. Bates,
Federal Advisory Committee Management Officer.
[FR Doc. 2012-7184 Filed 3-23-12; 8:45 am]
BILLING CODE 7590-01-P